ADT associated with increased risk for diabetes, CHD

Men of any age treated for prostate cancer with gonadotropin-releasing hormone agonists, or androgen deprivation therapy, had an increased risk for diabetes and cardiovascular disease in an observational study. Specifically, the risk was increased for diabetes, myocardial infarction, stroke, sudden cardiac death and coronary heart disease.

FULL STORY